With an entrepreneur making a name in the high-stakes world of medical research, the first instinct of those watching is usually one that is prepared to witness the typical pattern of Silicon Valley-style disruption. One would anticipate a media event announcing the creation of just one supercomputer or one lab built with the intention of finding a cure. This is a typical model of generosity that involves building monuments to the individual rather than enhancing science as a whole.
Nonetheless, social innovation may flip the tables on this strategic thinking by focusing attention on addressing the bureaucratic delays that prevent new findings from ever reaching the patient at all. In the highly competitive world of oncology research, openness is not a question of funding alone but demands that institutions come together to share knowledge.
